Literature DB >> 17971486

Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.

Shibin Ma1, Simanta Pathak, Long Trinh, Runqing Lu.   

Abstract

Pre-B lymphocytes consist of 2 distinct cell populations: large pre-B and small pre-B. The large pre-B cells are newly generated pre-B cells that express pre-B-cell receptor (pre-BCR) on the surface and are highly proliferative; small pre-B cells are derived from large pre-B cells that have down-regulated pre-BCR and withdrawn from cell cycle. The molecular events that mediate the transition from cycling pre-B to small, resting pre-B have not been fully elucidated. Here, we show that interferon regulatory factors 4 and 8 (IRF4,8) suppress surrogate light chain expression and down-regulate pre-BCR in pre-B cells. Our studies further reveal that IRF4,8 induce the expression of Ikaros and Aiolos in pre-B cells, and reconstitution of expression of either one is sufficient to suppress surrogate light chain expression and down-regulate pre-BCR in pre-B cells lacking IRF4,8. Interestingly, our results also indicate that pre-B cells undergo growth inhibition and cell-cycle arrest in the presence of IRF4,8. Moreover, we provide evidence that Ikaros and Aiolos are indispensable for the down-regulation of pre-BCR and the cell-cycle withdrawal mediated by IRF4,8. Thus, IRF4,8 orchestrate the transition from large pre-B to small pre-B cells by inducing the expression of Ikaros and Aiolos.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971486      PMCID: PMC2214771          DOI: 10.1182/blood-2007-08-110106

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  Differential surrogate light chain expression governs B-cell differentiation.

Authors:  Yui-Hsi Wang; Robert P Stephan; Alexander Scheffold; Désirée Kunkel; Hajime Karasuyama; Andreas Radbruch; Max D Cooper
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

2.  Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.

Authors:  P Sabbattini; M Lundgren; A Georgiou; C Chow ; G Warnes; N Dillon
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

3.  A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.

Authors:  Stefan A Muljo; Mark S Schlissel
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

Review 4.  The transient expression of pre-B cell receptors governs B cell development.

Authors:  Peter D Burrows; Robert P Stephan; Yui-Hsi Wang; Kaïss Lassoued; Zhixin Zhang; Max D Cooper
Journal:  Semin Immunol       Date:  2002-10       Impact factor: 11.130

5.  The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage.

Authors:  H Jumaa; M Mitterer; M Reth; P J Nielsen
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

6.  Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway.

Authors:  H E Fleming; C J Paige
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

7.  Combined deficiencies in Bruton tyrosine kinase and phospholipase Cgamma2 arrest B-cell development at a pre-BCR+ stage.

Authors:  Shengli Xu; Koon-Guan Lee; Jianxin Huo; Tomohiro Kurosaki; Kong-Peng Lam
Journal:  Blood       Date:  2006-12-12       Impact factor: 22.113

8.  Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts.

Authors:  Sujatha Nagulapalli; Aisha Goheer; Leslie Pitt; Lawrence P McIntosh; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  VpreB1/VpreB2/lambda 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus.

Authors:  Takeyuki Shimizu; Cornelia Mundt; Steve Licence; Fritz Melchers; Inga-Lill Mårtensson
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

10.  Loss of precursor B cell expansion but not allelic exclusion in VpreB1/VpreB2 double-deficient mice.

Authors:  C Mundt; S Licence; T Shimizu; F Melchers; I L Mårtensson
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

View more
  55 in total

1.  Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression.

Authors:  Shibin Ma; Simanta Pathak; Malay Mandal; Long Trinh; Marcus R Clark; Runqing Lu
Journal:  Mol Cell Biol       Date:  2010-06-21       Impact factor: 4.272

Review 2.  IRF8 regulates myeloid and B lymphoid lineage diversification.

Authors:  Hongsheng Wang; Herbert C Morse
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

3.  The BCL11A transcription factor directly activates RAG gene expression and V(D)J recombination.

Authors:  Baeck-seung Lee; Joseph D Dekker; Bum-kyu Lee; Vishwanath R Iyer; Barry P Sleckman; Arthur L Shaffer; Gregory C Ippolito; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2013-02-25       Impact factor: 4.272

4.  The miR-15 family reinforces the transition from proliferation to differentiation in pre-B cells.

Authors:  Silke E Lindner; Michael Lohmüller; Bianka Kotkamp; Fabian Schuler; Zeynep Knust; Andreas Villunger; Sebastian Herzog
Journal:  EMBO Rep       Date:  2017-07-13       Impact factor: 8.807

5.  Identification of sequence variants influencing immunoglobulin levels.

Authors:  Stefan Jonsson; Gardar Sveinbjornsson; Aitzkoa Lopez de Lapuente Portilla; Bhairavi Swaminathan; Rosina Plomp; Gillian Dekkers; Ram Ajore; Mina Ali; Arthur E H Bentlage; Evelina Elmér; Gudmundur I Eyjolfsson; Sigurjon A Gudjonsson; Urban Gullberg; Arnaldur Gylfason; Bjarni V Halldorsson; Markus Hansson; Hilma Holm; Åsa Johansson; Ellinor Johnsson; Aslaug Jonasdottir; Bjorn R Ludviksson; Asmundur Oddsson; Isleifur Olafsson; Sigurgeir Olafsson; Olof Sigurdardottir; Asgeir Sigurdsson; Lilja Stefansdottir; Gisli Masson; Patrick Sulem; Manfred Wuhrer; Anna-Karin Wihlborg; Gudmar Thorleifsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Gestur Vidarsson; Ingileif Jonsdottir; Björn Nilsson; Kari Stefansson
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

6.  A role for IRF8 in B cell anergy.

Authors:  Simanta Pathak; Shibin Ma; Vipul Shukla; Runqing Lu
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

7.  IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Authors:  Rossana Maffei; Stefania Fiorcari; Stefania Benatti; Claudio Giacinto Atene; Silvia Martinelli; Patrizia Zucchini; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

8.  Cutting edge: cell-autonomous control of IL-7 response revealed in a novel stage of precursor B cells.

Authors:  Gabriel J Sandoval; Daniel B Graham; Deepta Bhattacharya; Barry P Sleckman; Ramnik J Xavier; Wojciech Swat
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

9.  A role for interferon regulatory factor 4 in receptor editing.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; Runqing Lu
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

10.  Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.

Authors:  Daniel Trageser; Ilaria Iacobucci; Rahul Nahar; Cihangir Duy; Gregor von Levetzow; Lars Klemm; Eugene Park; Wolfgang Schuh; Tanja Gruber; Sebastian Herzog; Yong-mi Kim; Wolf-Karsten Hofmann; Aihong Li; Clelia Tiziana Storlazzi; Hans-Martin Jäck; John Groffen; Giovanni Martinelli; Nora Heisterkamp; Hassan Jumaa; Markus Müschen
Journal:  J Exp Med       Date:  2009-07-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.